TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the ED
NCT ID: NCT02611583
Last Updated: 2017-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-06-24
2016-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TENS for Back Pain Emergency Department
NCT04227067
Transcutaneous Electrical Nerve Stimulation for Back Pain in the Emergency Department (TENS-ED)
NCT05601843
TENS Efficacy on Acute Back Pain in an Emergency Department Triage
NCT03905681
Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation at the Emergency Department: a Randomized Controlled Trial
NCT07183176
Transcutaneous Electrical Nerve Stimulation (TENS) and Low Back Pain
NCT05812885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a two-arm, double blind, randomized control trial evaluating the patient perceived improvement in back pain. Patients will first fill out a Visual Analog Scale (VAS).
Patients will be randomized to one of two arms. Ibuprofen 800 mg, plus sham TENS for 45 minutes Ibuprofen 800 mg, plus TENS for 45 minutes
Patients will be given a 2nd VAS scale up to 15 minutes after the end of the TENS session. After the second VAS the patients will be finished with the study procedures and can be continued to be cared as per the discretion of their treating physician.
Our intention is to detect a 20% reduction in pain by VAS with a common standard deviation equal to the difference at the p = 0.05 level with a power of 80% using an analysis of variance (ANOVA). The calculated sample size required 28 patients per group. Considering the uncertain dropout rate, the investigators decided to enroll at least 66 patients. Baseline characteristics will be calculated to determine if groups are equal. A two-way repeated-measures ANOVA will be used to test both a trial effect and a group effect (SPSS 20, SPSS Inc., Chicago, IL). Data will be presented as means with standard deviations with 95% confidence intervals. A p\< 0.05 was considered statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ibuprofen and TENS plus
Patients will receive 45 minutes of TENS therapy. All patients will receive ibuprofen.
TENS
Transcutaneous Electrical Nerve Stimulation
Ibuprofen and Sham TENS plus
Patients will receive 45 minutes of sham TENS therapy. All patients will receive ibuprofen.
TENS
Transcutaneous Electrical Nerve Stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS
Transcutaneous Electrical Nerve Stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient is receiving 800mg dose of ibuprofen as part of their treatment regimen for back pain
3. Back pain new in the last 48 hours
4. Deemed by the treating physician to have musculoskeletal back pain, and no central/peripheral nervous system pathology as the cause of their pain.
Exclusion Criteria
2. Hypotension (MAP \<65 or Systolic BP \<100), fever, tachycardia
3. Paresthesias, isolated motor weakness, or objective sensory deficit on physical exam
4. Radicular symptoms
5. Urinary incontinence or retention
6. Bowel incontinence
7. Unexplained weight loss of \>15 lbs in the last 3 months.
8. Multiple primary complaints in the ED.
9. Received Analgesia other than Ibuprofen as part of their ED work up.
10. Taken prescription strength pain medication within the last 12 hours for any condition.
11. History of active malignancy, HIV, organ transplantation, active hemodialysis
12. Currently pregnant
13. Nursing home residents
14. Currently in police custody
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Albert Einstein Healthcare Network
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Dominici
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul G Dominici, MD
Role: PRINCIPAL_INVESTIGATOR
Albert Einstein Healthcare Network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albert Einstein Healthcare Network
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cypress BK. Characteristics of physician visits for back symptoms: a national perspective. Am J Public Health. 1983 Apr;73(4):389-95. doi: 10.2105/ajph.73.4.389.
Patrick N, Emanski E, Knaub MA. Acute and chronic low back pain. Med Clin North Am. 2014 Jul;98(4):777-89, xii. doi: 10.1016/j.mcna.2014.03.005.
Thorsteinsson G, Stonnington HH, Stillwell KG, Elveback LR. The placebo effect of transcutaneous electrical stimulation. Pain. 1978 Jun;5(1):31-41. doi: 10.1016/0304-3959(78)90022-2.
Marchand S, Charest J, Li J, Chenard JR, Lavignolle B, Laurencelle L. Is TENS purely a placebo effect? A controlled study on chronic low back pain. Pain. 1993 Jul;54(1):99-106. doi: 10.1016/0304-3959(93)90104-W.
Bertalanffy A, Kober A, Bertalanffy P, Gustorff B, Gore O, Adel S, Hoerauf K. Transcutaneous electrical nerve stimulation reduces acute low back pain during emergency transport. Acad Emerg Med. 2005 Jul;12(7):607-11. doi: 10.1197/j.aem.2005.01.013.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HN4810
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.